Infected Thrombus of the Bioprosthetic Aortic Valve with Distal Arterial Embolization after 3 Years of Valve Replacement Surgery.
- Author:
Jung Ae HONG
1
;
Sung Ai KIM
Author Information
1. Division of Cardiology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea. 237419@hallym.or.kr
- Publication Type:Case Report
- Keywords:
Infection;
Thrombosis;
Endocarditis;
Bioprosthesis;
Aortic valve
- MeSH:
Aged;
Aortic Valve*;
Bioprosthesis;
Echocardiography;
Endocarditis;
Humans;
Incidence;
Male;
Risk Factors;
Thromboembolism;
Thrombosis*;
Warfarin
- From:Soonchunhyang Medical Science
2015;21(2):180-183
- CountryRepublic of Korea
- Language:English
-
Abstract:
Current guidelines recommend the use of warfarin in the first 3 months after bioprosthetic valve replacement and suggest long-term anticoagulation only in patients with obvious risk factors for thrombosis. Despite at low risk of thromboembolism, we present a case of a 72-year-old male patient with infected thrombus at bioprosthetic aortic valve with distal arterial embolization after 3 years of replacement surgery. The incidence of asymptomatic bioprosthetic valve thrombosis (BPVT) may be higher than anticipated and active surveillance echocardiography is needed to early detect BPVT before leading to fatal complication.
